Dose finding study with irinotecan (CPT-11) in previously treated colo-rectal cancer

被引：0
|
作者：
Viéitez, JM
Carrasco, J
Fra, J
Muñiz, I
Esteban, E
Palacio, I
Sala, M
Puertas, J
Estrada, E
Buesa, JM
Lacave, AJ
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] Utilization and cost of CPT-11 (C) in elderly previously treated metastatic colorectal cancer (MCRC) patients (pts).
    Eng, C
    Zhao, L
    Shih, YCT
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 266S - 266S
  • [42] INTESTINAL-OBSTRUCTION BY COLO-RECTAL CANCER - STUDY OF 43 CASES
    MIGUEL, FJC
    VIDAUR, FA
    FERNANDEZ, JM
    CASADO, MTD
    SANJUAN, ARD
    REVISTA ESPANOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO, 1982, 62 (04): : 291 - 298
  • [43] Pharmacokinetics of irinotecan (CPT-11) in patients treated with neomycin to diminish β-glucuronidase activity in the intestines.
    Sparreboom, A
    Kehrer, D
    Verweij, J
    De Bruijn, P
    De Jonge, MJA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3846S - 3846S
  • [44] Irinotecan (CPT-11) as first line treatment of patients with not pretreated advanced colorectal cancer
    Firyida, JL
    Menendez, MD
    Mel, JR
    Diz, P
    Constenla-Figueiras, M
    Casal, J
    Valladares, M
    Castellanos, J
    Balcells, M
    ANNALS OF ONCOLOGY, 1998, 9 : 38 - 39
  • [45] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Heather Wakelee
    George A. Fisher
    Investigational New Drugs, 2005, 23 : 241 - 242
  • [46] A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer
    Wakelee, H
    Fisher, GA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (03) : 241 - 242
  • [47] CPT-11 (irinotecan) and 5-fluorouracil: A promising combination for therapy of colorectal cancer
    Saltz, L
    Shimada, Y
    Khayat, D
    EUROPEAN JOURNAL OF CANCER, 1996, 32A : S24 - S31
  • [48] Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer
    Tatsuru Ohara
    Yoichi Kobayashi
    Ayako Yoshida
    Norihito Yoshioka
    Namiko Yahagi
    Haruhiro Kondo
    Akiko Tozawa
    Kazushige Kiguchi
    Nao Suzuki
    International Journal of Clinical Oncology, 2013, 18 : 1102 - 1106
  • [49] Combination of irinotecan (CPT-11) and nedaplatin (NDP) for recurrent patients with uterine cervical cancer
    Ohara, Tatsuru
    Kobayashi, Yoichi
    Yoshida, Ayako
    Yoshioka, Norihito
    Yahagi, Namiko
    Kondo, Haruhiro
    Tozawa, Akiko
    Kiguchi, Kazushige
    Suzuki, Nao
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1102 - 1106
  • [50] Irinotecan (CPT-11): Recent developments and future directions-colorectal cancer and beyond
    Rothenberg, ML
    ONCOLOGIST, 2001, 6 (01): : 66 - 80
12345